ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.430,05
1,42%
S&P 500
5.187,70
0,13%
Dow Jones
38.884,26
0,08%
Euro vs US Dollar
1,07551
-0,11%
Bitcoin
62.993,85
-0,27%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Evofem Biosciences Inc (EVFM)

  7. Evofem Biosciences Inc (EVFM) News

EVFM

Evofem Biosciences (EVFM)

Evofem Biosciences Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:EVFM
DatumZeitQuelleÜberschriftSymbolFirma
16/06/202323h01Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EVFMEvofem Biosciences Inc
16/06/202322h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EVFMEvofem Biosciences Inc
01/06/202314h36Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EVFMEvofem Biosciences Inc
01/06/202314h36PR Newswire (US)Evofem Biosciences Announces Strong Preliminary Results for the First Quarter of 2023NASDAQ:EVFMEvofem Biosciences Inc
17/05/202323h14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EVFMEvofem Biosciences Inc
17/05/202322h50PR Newswire (US)Evofem Biosciences Announces 1-for-125 Reverse Stock SplitNASDAQ:EVFMEvofem Biosciences Inc
12/05/202322h16Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:EVFMEvofem Biosciences Inc
28/04/202312h57Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EVFMEvofem Biosciences Inc
27/04/202323h29Edgar (US Regulatory)Annual Report (10-k)NASDAQ:EVFMEvofem Biosciences Inc
12/04/202314h48PR Newswire (US)Evofem Wins Phexxi Coverage with Largest Payer in New York with No Prior Authorization RequiredNASDAQ:EVFMEvofem Biosciences Inc
12/04/202312h02Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:EVFMEvofem Biosciences Inc
31/03/202322h03Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:EVFMEvofem Biosciences Inc
24/03/202321h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EVFMEvofem Biosciences Inc
21/03/202313h48PR Newswire (US)Evofem Biosciences Announces Cost Reduction MeasuresNASDAQ:EVFMEvofem Biosciences Inc
17/03/202311h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EVFMEvofem Biosciences Inc
14/03/202314h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EVFMEvofem Biosciences Inc
09/03/202312h50PR Newswire (US)Evofem Biosciences Appoints Interim Chief Financial OfficerNASDAQ:EVFMEvofem Biosciences Inc
06/03/202320h49Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:EVFMEvofem Biosciences Inc
28/02/202314h48PR Newswire (US)Evofem's Phexxi Contraceptive Gel Added to SimpleHealth Product OfferingNASDAQ:EVFMEvofem Biosciences Inc
27/02/202313h46PR Newswire (US)Evofem Biosciences Announces FDA Orange Book Listing of Two Additional U.S. Patents for PhexxiNASDAQ:EVFMEvofem Biosciences Inc
24/02/202312h04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EVFMEvofem Biosciences Inc
23/02/202314h34PR Newswire (US)Evofem Biosciences to Explore Strategic Alternatives to Maximize Shareholder ValueNASDAQ:EVFMEvofem Biosciences Inc
15/02/202322h01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:EVFMEvofem Biosciences Inc
27/01/202312h05Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:EVFMEvofem Biosciences Inc
12/01/202320h23Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EVFMEvofem Biosciences Inc
10/01/202314h36PR Newswire (US)Costco Adds Phexxi® to Member Prescription ProgramNASDAQ:EVFMEvofem Biosciences Inc
09/01/202317h11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EVFMEvofem Biosciences Inc
09/01/202314h54PR Newswire (US)Multiple New Insurance Wins Expand and Improve Access to Phexxi® for Millions of WomenNASDAQ:EVFMEvofem Biosciences Inc
30/12/202215h26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EVFMEvofem Biosciences Inc
21/12/202223h28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EVFMEvofem Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:EVFM

Kürzlich von Ihnen besucht

CCOM
SILVER
SILVER
NASDAQ
GOOGL
Alphabet
DBI
DAX
DAX
TG
BAS
BASF
TG
DTE
Deutsche Telekom
TG
NOV
Novo Nordisk
DBI
SDXP
SDAX
CCOM
US100
US Tech 100
NYSE
JPM
JP Morgan Chase
AMEX
SPY
SPDR S&P 500
TG
CBK
Commerzbank
NASDAQ
AMZN
Amazon.com
TG
DBK
Deutsche Bank
COIN
SOLUSD
Solana
NASDAQ
AAPL
Apple
NYSE
XOM
Exxon Mobil
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten